Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.


http://dlvr.it/T79LGQ

Comments

Post a Comment

Popular posts from this blog

GLP-1 Drugs Before Bariatric Surgery Can Help People With Extreme Obesity

Image
A new study looked at the impact of taking GLP-1 drugs before bariatric surgery. Halfpoint/Getty Images * New research finds that using GLP-1 drugs like Ozempic before bariatric surgery can help improve the health of people with extreme obesity. * Extreme obesity is defined as having a body mass index (BMI) of 70 or more. * In 2022, there were nearly 280,000 metabolic and bariatric surgeries in the United States. People with extreme obesity can reduce their risk of complications from bariatric or metabolic surgery by taking GLP-1 drugs before the procedures, according to a study presented over the weekend at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting. The results of the study haven’t yet been published in a peer-reviewed scientific journal. Extreme obesity, which is defined as having a body mass index (BMI) of 70 or more, presents patients and doctors with complications during and after weight-loss surgery c...
Read more